Alexandra Vallon Eberhard, Senior Director Global Diagnostics BD, Roche

Dr. Alexandra Vallon-Eberhard, Senior Director Global Business Development- Diagnostics Biomarkers and Digital Healthcare Solutions at Roche

Dr. Alexandra Vallon-Eberhard

Senior Director Global Diagnostics BD

Dr. Alexandra Vallon-Eberhard has over 15 years of extensive international business

development, investment, innovation and managerial experience. She is focusing her work

on personalized patient care and digital healthcare solutions, currently serving as Senior

Director Global Business Development – Diagnostics Biomarkers and Digital Healthcare

Solutions at Roche.

Alexandra successfully co-built the 2019 Frost & Sullivan awarded next-gen data platform

(Sequoia-backed) and supported over 40 of the fortune 500 companies in their

inorganic/venture growth strategy in the era of digital transformation. Over the past 10 years,

Alexandra has accompanied Israeli and Swiss start-ups in their financial, strategic and

operational growth.

Since 2020, she is a proud board member of the Weizmann Young European Network,

expert member of the digital health hub @Lausanne Biopole and volunteer of the Healthcare

Businesswomen’s Association.

Alexandra earned her PhD in Immunology/Virology at bioMerieux (France), her post-

doctorate at the Weizmann Institute of Science (Israel) and received six academic awards.

Alexandra also earned an International MBA from Bar Ilan University (Israel).